Genomic Information of Breast Cancer Tumors Drives Precision Medicine Treatment With Dr. Bill Audeh Agendia

Published: Nov. 25, 2020, 4:49 p.m.

Dr. Bill Audeh, medical oncologist and Chief Medical Officer, Agendia left his 30 year career of medical practice treating breast cancer patients to join Agendia because of the exciting opportunities for precision medicine to treat breast cancer. With technology that allows for genomic testing of the cancer tumors, it can be determined how likely it is that the cancer could spread and identifies what's driving the cancer's growth.  With this data, physicians can be informed about the best treatment for each individual patient.

@agendia #precisionmedicine #genomictesting #breastcancer

Agendia.com

Download the transcript here

Agendia